Î³Î´ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors.

Tian, Wei; Ma, Jun; Shi, Ruyi; Ren, Chongren; He, Jiefeng; Zhao, Haoliang

Tian, Wei; Ma, Jun; Shi, Ruyi; Ren, Chongren; He, Jiefeng; Zhao, Haoliang.

Afiliação

Tian W; The First Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Ma J; Department of General Surgery, Taiyuan Central Hospital, Taiyuan, Shanxi 030009, P.R. China.
Shi R; Department of General Surgery, Shanxi Dayi Hospital, Shanxi Academy of Medical Sciences, Taiyuan, Shanxi 030032, P.R. China.
Ren C; The First Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
He J; Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.
Zhao H; Department of Cell Biology and Genetics, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China.

Oncol Lett ; 15(4): 5433-5442, 2018 Apr.

Article em En | MEDLINE | ID: mdl-29552184